Q. Zhou-Liu

SAR650984, A Novel Humanized CD38-Targeting Antibody, Demonstrates Potent Antitumor Activity in Models of Multiple Myeloma and Other CD38+ Hematologic Malignancies

J. Deckert, T. Chittenden, A. Plesa, 2014, Clinical Cancer Research.

Cancer Therapy : Preclinical SAR 650984 , A Novel Humanized CD 38-Targeting Antibody , Demonstrates Potent AntitumorActivity inModels ofMultiple Myeloma and Other CD 38 þ Hematologic Malignancies

C. Dumontet, P. Ferrari, V. Goldmacher, 2014 .

Cancer Therapy: Preclinical SAR650984, A Novel Humanized CD38-Targeting Antibody, Demonstrates Potent AntitumorActivity inModels ofMultiple Myeloma and Other CD38þ Hematologic Malignancies

C. Dumontet, P. Ferrari, V. Goldmacher, 2014 .

Crystal structures of the catalytic domain of HIV-1 integrase free and complexed with its metal cofactor: high level of similarity of the active site with other viral integrases.

V. Mikol, S Maignan, Q. Zhou-Liu, 1998, Journal of molecular biology.

Abstract 4648: In vitro characterization of spiro-oxindole-based modulators of the MDM2-p53 interaction and their interspecies selectivity.

Shaomeng Wang, J. Watters, C. García-echeverría, 2012 .

SAR650984, A Novel Humanized CD38-Targeting Antibody, Demonstrates Potent Antitumor Activity in Models of Multiple Myeloma and Other CD38+ Hematologic Malignancies

T. Chittenden, A. Plesa, M. Chiron, 2014, Clinical Cancer Research.